CELLINK Acquires Nanoscribe, Visikol | Business | May 2021 photonics.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from photonics.com Daily Mail and Mail on Sunday newspapers.
Since 2004, Rohde & Schwarz has been organizing the international Engineering Competition. This year, the entire competition was held online. The internatio
Büro und Homeoffice: Mischform tut Mitarbeitern nicht gut wiwo.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wiwo.de Daily Mail and Mail on Sunday newspapers.
Karlsruhe Institute of Technology
Specialized software is used in almost all scientific fields, but its quality is not always good. (Photo: Markus Breig, KIT)
Computational tools are indispensable in almost all scientific disciplines. Especially in cases where large amounts of research data are generated and need to be quickly processed, reliable, carefully developed software is crucial for analyzing and correctly interpreting such data – e.g., in biology, physics, or, very recently, in epidemiology. However, the development and maintenance of scientific software are often characterized by uncertain funding and time pressure, which can lead to quality deficiencies. To evaluate software quality in an automated way, computer scientists at Karlsruhe Institute of Technology (KIT) and Heidelberg Institute for Theoretical Studies (HITS) have designed the SoftWipe tool. They published their findings in the Nature Scientific Reports journal.
Cellink targets lab-on-a-chip applications with Nanoscribe acquisition
25 May 2021
Swedish bio-printing pioneer says it will gain a âleg upâ on competition with cash-plus-stock deal worth up to â¬50M.
Nanoscribe, the spin-out from the Karlsruhe Institute of Technology (KIT) that developed two-photon polymerization tools to make tiny, intricate structures, is set to become part of the fast-growing Swedish life sciences firm Cellink.
The two firms have agreed a cash-plus-stock deal that will see Cellink pay an initial â¬34 million for Nanoscribe, plus up to an additional â¬16 million in earn-outs if financial targets are met.
Assuming that the acquisition proceeds as expected, Nanoscribe will join forces with several other recent purchases made by Cellink, as the firm looks to build a portfolio of cutting-edge technologies that it believes will revolutionize biology and healthcare.